Dyadic International (DYAI) EPS (Basic) (2018 - 2026)
Dyadic International's (DYAI) quarterly EPS (Basic) came in at -$0.05 in Q1 2026, up 21.72% year-over-year from -$0.04 in Q1 2025, and down 12.6% quarter-over-quarter from -$0.05 in Q4 2025.
Powered by 
Analysis
Dyadic International (DYAI) EPS (Basic) (2018 - 2026) Analysis & Trends
Dyadic International has disclosed EPS (Basic) across 9 years of filings, most recently posting -$0.05 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 21.72% year-over-year to -$0.05; the TTM figure through Mar 2026 stood at -$0.2 (down 3.41% YoY), while the FY2025 annual figure was -$0.22, down 13.52% from the prior year.
- EPS (Basic) came in at -$0.05 for Q1 2026 at Dyadic International, down from -$0.05 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.01 in Q3 2024 to a low of -$0.12 in Q2 2022.
- Average EPS (Basic) over 5 years is -$0.06, with a median of -$0.07 recorded in 2025.
- Year-over-year, EPS (Basic) surged 99.92% in 2022 and plunged 914.74% in 2025.
- Over 5 years, EPS (Basic) stood at -$0.08 in 2022, then advanced by 4.93% to -$0.07 in 2023, then climbed by 28.15% to -$0.05 in 2024, then rose by 9.84% to -$0.05 in 2025, then slipped by 12.6% to -$0.05 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.05 in Q1 2026, -$0.05 in Q4 2025, and -$0.06 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.59 Bn | 192.60 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 180.21 Bn | 177.03 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 131.41 Bn | 123.56 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.94 Bn | 73.94 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.60 Bn | 55.41 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 53.61 Bn | 48.47 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.49 Bn | 30.18 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.83 Bn | 30.54 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.14 Bn | 29.14 Bn | 1.16 Mn | -0.40 |
| 10 | Dyadic International | 18.44 Mn | 10.48 Mn | - | -0.05 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -0.05 |
| Dec 31, 2025 | -0.05 |
| Sep 30, 2025 | -0.06 |
| Jun 30, 2025 | -0.06 |
| Mar 31, 2025 | -0.07 |
| Dec 31, 2024 | -0.05 |
| Sep 30, 2024 | -0.01 |
| Jun 30, 2024 | -0.07 |
| Mar 31, 2024 | -0.07 |
| Dec 31, 2023 | -0.07 |
| Sep 30, 2023 | -0.06 |
| Jun 30, 2023 | -0.08 |
| Mar 31, 2023 | -0.07 |
| Dec 31, 2022 | -0.08 |
| Sep 30, 2022 | -0.06 |
| Jun 30, 2022 | -0.12 |
| Mar 31, 2022 | -0.10 |
| Dec 31, 2021 | -0.15 |
| Sep 30, 2021 | -0.12 |
| Jun 30, 2021 | -0.14 |